deltatrials
Unknown PHASE4 INTERVENTIONAL 2-arm NCT01968798

ASPREE Cancer Endpoints Study (ACES)

Sponsor: Bayer

Conditions Cancer
Interventions Aspirin Placebo
Updated 14 times since 2017 Last updated: Apr 2, 2021 Started: Sep 30, 2013 Primary completion: Jan 31, 2019 Completion: Apr 30, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Cancer and is currently ongoing. Bayer leads this study, which shows 14 recorded versions since 2013 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Aug 2017 · 6 months · monthly snapshot~Aug 2017 – ~Jun 2018 · 10 months · monthly snapshot~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshot~Jan 2019 – ~May 2019 · 4 months · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Apr 2020 · 10 months · monthly snapshot~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshot~Jan 2021 – ~May 2021 · 4 months · monthly snapshot~May 2021 – ~May 2024 · 36 months · monthly snapshot~May 2024 – ~Jul 2024 · 2 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2025 — Present [monthly]

    Unknown PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Unknown PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown Status → Unknown

  4. May 2024 — Jul 2024 [monthly]

    Unknown Status PHASE4

    Status: Active Not Recruiting → Unknown Status

  5. May 2021 — May 2024 [monthly]

    Active Not Recruiting PHASE4

▶ Show 9 earlier versions

  1. Jan 2021 — May 2021 [monthly]

    Active Not Recruiting PHASE4

  2. Apr 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE4

  3. Jun 2019 — Apr 2020 [monthly]

    Active Not Recruiting PHASE4

  4. May 2019 — Jun 2019 [monthly]

    Active Not Recruiting PHASE4

  5. Jan 2019 — May 2019 [monthly]

    Active Not Recruiting PHASE4

    Status: Enrolling By Invitation → Active Not Recruiting

  6. Jun 2018 — Jan 2019 [monthly]

    Enrolling By Invitation PHASE4

  7. Aug 2017 — Jun 2018 [monthly]

    Enrolling By Invitation PHASE4

  8. Feb 2017 — Aug 2017 [monthly]

    Enrolling By Invitation PHASE4

  9. Jan 2017 — Feb 2017 [monthly]

    Enrolling By Invitation PHASE4

    First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bayer
  • Berman Center for Outcomes and Clinical Research
  • Hennepin Healthcare Research Institute
  • Monash University
  • National Cancer Institute (NCI)
  • National Health and Medical Research Council, Australia
  • National Institute on Aging (NIA)
Data source: Hennepin Healthcare Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ann Arbor, United States , Atlanta, United States , Augusta, United States , Baton Rouge, United States , Birmingham, United States , Brooklyn, United States , Chicago, United States , Covington, United States , Dallas, United States , Detroit, United States and 25 more locations